Results of the two incidence screenings in the National Lung Screening Trial.
about
Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literatureRisk factors assessment and risk prediction models in lung cancer screening candidatesImplementing lung cancer screening in the real world: opportunity, challenges and solutionsScreening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individualsComponents necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy StatementManagement strategy of solitary pulmonary nodulesLung cancer screening with low-dose computed tomography for primary care providersCost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.Blizzard Sign as a specific endobronchial ultrasound image for ground glass opacity: A case report.Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaData-driven decision support for radiologists: re-using the National Lung Screening Trial dataset for pulmonary nodule management.Small cell lung cancer: where do we go from here?A Bayesian model for estimating multi-state disease progressionValidation of a blood protein signature for non-small cell lung cancerPrevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study.Lung cancer screening: subsequent evidences of national lung screening trial.Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.CHoMP: a chemoenzymatic histology method using clickable probes.The Hundred Person Wellness Project and Google's Baseline Study: medical revolution or unnecessary and potentially harmful over-testing?Very low-dose (0.15 mGy) chest CT protocols using the COPDGene 2 test object and a third-generation dual-source CT scanner with corresponding third-generation iterative reconstruction software.Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept studyIncidentally diagnosed pulmonary nodule: a diagnostic algorithm.Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trialsSignificance of plasma hepatocyte growth factor in diagnosis of benign and malignant solitary pulmonary nodules.Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomographyESR/ERS white paper on lung cancer screeningClinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case-control study.Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstructionDiagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography.The Fate of Patients with Solitary Pulmonary Nodules: Clinical Management and Radiation Exposure AssociatedDifferences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.Significance of pulmonary nodules in multi-detector computed tomography scan of noncancerous patients.Lung cancer screening using low dose CT: screening population and positive results definition.Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules[Systematic Review of the Methodology Quality in Lung Cancer Screening Guidelines].Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population.
P2860
Q23911871-E22D050D-B656-4968-907B-BA84E949C33EQ26747819-A8B691D1-E52A-46AE-93EF-7C39BF7BFCE9Q26784107-1A73E6AA-4F45-4934-9173-9C0E90624372Q26799888-4040AF05-2C20-4295-AD31-749E5673C932Q27021984-D442CB18-F64C-49FC-A1D5-E7BE5235D5D7Q27022971-133489FF-BF48-4B62-9C1A-54F1C545EB83Q28390878-EE507BAA-9031-470D-82D0-EBCB7ECF9895Q30251912-66D67E89-BA91-44AB-A59F-55D0AA5769B1Q30428509-30BEE47F-2168-4BE8-AC0A-298A1ED024EEQ30587070-A7E7E6A8-754C-4D43-8022-078025F745A2Q30833381-C752FFDA-3CAD-46E1-8D92-935FB1B352A8Q33872327-42A05476-8018-4449-B7DF-8B0C9A408927Q33900778-4D59DDB6-183A-4E84-A42C-68881892518DQ34008245-F62FD8E6-B3D4-4966-B9B4-D2EA78F9E972Q34021407-4340B861-071B-4C0D-B67E-73BEB901CC94Q34195009-6B79AE7A-9B19-4468-AAB6-EA911DD6364EQ34396038-B865E1DF-FDED-42D1-B019-C66A2A9A2478Q34665081-11074F3A-0E09-4F49-BE93-844C6ECAB05DQ34785017-21BE4C7C-96EC-46BF-9771-E8C59001A913Q34887066-303A013B-7C7A-424C-9236-482D19A42BD4Q34956435-28AA35D3-589A-47C2-A138-9E39C90112A6Q35112929-DECD8543-BD32-459F-9169-22F81940B393Q35145639-ED93DA9C-322A-4958-BBB4-4F9756A25F51Q35171942-E8A9A937-02A7-4E58-A403-58E2AD437677Q35406935-85BD4DFC-7C52-4108-A92E-438195ECDAA8Q35616872-ADDC5EB6-5609-4EDD-869D-41923864507DQ35718230-AE22A034-0E4C-4CA0-BAB4-1A5E969A37EEQ35801394-54116A3E-59EF-42BF-BD63-3790DA956C21Q35826719-70EE774D-7CA7-46BF-9F5B-480E4F27284DQ35876638-B689C83F-CDBA-4C4E-9445-757AE6FE25D7Q35935680-BA216300-DC96-4D2F-AC3E-BE826672E251Q35993714-7E9EB664-E6CE-4B0D-B2FB-EF338FCC39F2Q36024063-4D6EE18F-3ACE-4FC0-8C15-D37D59C55884Q36071723-4FAF2A04-CFD7-45D9-856B-4682BFEBC91AQ36100327-5C433CF0-4126-4279-9FA0-FA7AD8B3E5E6Q36110660-D676B380-7B1C-4C05-8CDE-692A3ABB0140Q36138370-BB9727A4-D0F9-4045-BC8C-5364AC608CA1Q36151227-4947C384-628F-4D20-AE5D-976B11D54F3BQ36168320-E0D5A8FB-5B11-4F6B-AECF-6C45D58E710DQ36180316-0B479739-AD9F-4FC3-809D-AD9C4B5C3E27
P2860
Results of the two incidence screenings in the National Lung Screening Trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Results of the two incidence screenings in the National Lung Screening Trial.
@ast
Results of the two incidence screenings in the National Lung Screening Trial.
@en
Results of the two incidence screenings in the National Lung Screening Trial.
@nl
type
label
Results of the two incidence screenings in the National Lung Screening Trial.
@ast
Results of the two incidence screenings in the National Lung Screening Trial.
@en
Results of the two incidence screenings in the National Lung Screening Trial.
@nl
prefLabel
Results of the two incidence screenings in the National Lung Screening Trial.
@ast
Results of the two incidence screenings in the National Lung Screening Trial.
@en
Results of the two incidence screenings in the National Lung Screening Trial.
@nl
P2093
P2860
P50
P356
P1476
Results of the two incidence screenings in the National Lung Screening Trial.
@en
P2093
Amanda Jain
Brenda Brewer
Christine D Berg
Constantine A Gatsonis
David S Gierada
Fenghai Duan
Gordon C Jones
Irene Mahon
JoRean Sicks
Joshua M Rathmell
P2860
P304
P356
10.1056/NEJMOA1208962
P407
P577
2013-09-01T00:00:00Z